Ugt1a1 (human) recombinant (partial protein gst tag) 10 µg
Produit ni repris ni échangé excepté en cas d’erreur du prestataire.
Points clés
Used for AP, Array, ELISA, WB-Re
This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The preferred substrate of this enzyme is bilirubin, although it also has moderate activity with simple phenols, flavones, and C18 steroids. Mutations in this gene result in Crigler-Najjar syndromes types I and II and in Gilbert syndrome. [provided by RefSeq]
Garantie
Garantie 0 Mois
Description
Used for AP, Array, ELISA, WB-Re
This gene encodes a UDP-glucuronosyltransferase, an enzyme of the glucuronidation pathway that transforms small lipophilic molecules, such as steroids, bilirubin, hormones, and drugs, into water-soluble, excretable metabolites. This gene is part of a complex locus that encodes several UDP-glucuronosyltransferases. The locus includes thirteen unique alternate first exons followed by four common exons. Four of the alternate first exons are considered pseudogenes. Each of the remaining nine 5' exons may be spliced to the four common exons, resulting in nine proteins with different N-termini and identical C-termini. Each first exon encodes the substrate binding site, and is regulated by its own promoter. The preferred substrate of this enzyme is bilirubin, although it also has moderate activity with simple phenols, flavones, and C18 steroids. Mutations in this gene result in Crigler-Najjar syndromes types I and II and in Gilbert syndrome. [provided by RefSeq]
Caractéristiques
- Type d'antibiotique
- non
- Marque
- ABNOVA
- Référence distributeur
- 16177676
- Fournisseur
- FISHER SCIENTIFIC S.A.S.
- Dispositif stérile
- non
- Marquage CE DIV
- non
- Code à barre
- non
- Type d'acide nucléique extrait
- non
- Origine humaine
- non
- Sans composant animal
- non
- Vendu par
- 10 ug
- Délai de péremption à la date de livraison
- 12 mois
- Température de conservation (°C)
- -80 °C
- Température de transport
- carboglace
- Soumis à carboglace
- oui
- Classification REACH
- non
- Code douanier
- 38229000
- Nomenclature IFPEN
- NA.55
- Nomenclature DGOS
- LD10AOOO
- Domaine de recherche
- protéomique
- Reprise en cas d’erreur client
- non
- Libellé produit fabricant
- 10ug ugt1a1 (human) recombinant protein (q01)
- Nomenclature Nacres
- NA.55
- Nomenclature IRSN
- 273
- Type de produit
- protéine
- Type d’application
- ELISA, western-Blot
- Nomenclature INSERM
- NA.NA55
- Lieu de stockage
- France
- Nomenclature CHU
- 18.551
- Autres caractéristiques
- Abnova Human UGT1A1 Partial ORF (NP_000454.1, 54 a.a. - 159 a.a.) Recombinant Protein with GST-tag at N-terminal, Quantity: 10 ug, Format: Liquid, Formulation: 50mM Tris-HCI, 10mM reduced Glutathione, pH-8.0 in the elution buffer., Host Species: Whea
- Lieu de fabrication
- Taïwan
- Nomenclature CEA
- SGP01
- Nomenclature CNRS
- NA55
- Matière dangereuse
- non
- Type d'échantillon
- protéine
- Quantité
- N/A
- Type d'enzyme
- non
- Type de protéine
- oui
- Référence fabricant
- H00054658-Q01
- Certification
- RUO

